Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 169,200 | 201,400 | 812,900 | 637,500 | 559,000 |
| Marketable Securities | 13,100 | 13,600 | 13,100 | 13,400 | 11,800 |
| Receivables | 543,800 | 517,400 | 377,100 | 356,600 | 353,600 |
| Inventories | 710,700 | 692,300 | 505,700 | 499,300 | 476,200 |
| Income taxes - deferred | 128,500 | 130,900 | 116,500 | 121,000 | 113,900 |
| TOTAL | $1,769,700 | $1,769,500 | $1,885,300 | $1,688,500 | $1,563,800 |
| Non-Current Assets | |||||
| PPE Net | 678,100 | 694,200 | 625,100 | 635,400 | 649,000 |
| Investments And Advances | 36,100 | 114,500 | 96,200 | 86,000 | 81,200 |
| Intangibles | 3,355,400 | 3,214,500 | 1,378,300 | 1,399,800 | 1,414,100 |
| Other Non-Current Assets | 50,900 | 110,800 | 40,900 | 40,700 | 42,800 |
| TOTAL | $4,120,500 | $4,134,000 | $2,140,500 | $2,161,900 | $2,187,100 |
| Total Assets | $5,890,200 | $5,903,500 | $4,025,800 | $3,850,400 | $3,750,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 85,000 | 307,600 | 1,600 | 726,400 | 626,400 |
| Accounts payable and accrued liabilities | 621,100 | 614,300 | 399,100 | 427,100 | 382,800 |
| TOTAL | $880,500 | $1,047,900 | $439,900 | $1,190,600 | $1,142,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,155,500 | 1,150,200 | 997,400 | 150,000 | 250,000 |
| Deferred Revenues | 24,900 | 16,300 | 21,100 | 22,500 | 22,000 |
| aiOther Non-Current Liabilities | 190,600 | 194,700 | 68,400 | 63,300 | 63,100 |
| TOTAL | $1,916,300 | $1,832,500 | $1,275,300 | $427,700 | $444,700 |
| Total Liabilities | $2,796,800 | $2,880,400 | $1,715,200 | $1,618,300 | $1,587,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 124,566 | 123,516 | 106,140 | 105,729 | 105,412 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 1,709,900 | 1,640,100 | 1,583,200 | 1,520,200 | 1,467,200 |
| Other shareholders' equity | -13,100 | 1,700 | -100 | 500 | -3,100 |
| TOTAL | $3,093,400 | $3,023,100 | $2,310,600 | $2,232,100 | $2,163,600 |
| Total Liabilities And Equity | $5,890,200 | $5,903,500 | $4,025,800 | $3,850,400 | $3,750,900 |